pharmaceutical investing OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth
Apex Commences Drilling at Jersey Emerald Property and Announces Amendment to Terms of Lithium Creek Option Agreement
